Are Insulet (NASDAQ:PODD) Shares Worth Your Time and Dime Following Recent BTIG Research Downgrade?

July 17, 2017 - By Dolores Ford

 Are Insulet (NASDAQ:PODD) Shares Worth Your Time and Dime Following Recent BTIG Research Downgrade?

Investors sentiment decreased to 0.87 in Q4 2016. Its down 0.25, from 1.12 in 2016Q3. It worsened, as 26 investors sold Insulet Corporation shares while 58 reduced holdings. 21 funds opened positions while 52 raised stakes. 60.26 million shares or 0.42% more from 60.00 million shares in 2016Q3 were reported.

Pacad Inv Ltd stated it has 0.02% of its portfolio in Insulet Corporation (NASDAQ:PODD). Blackrock Group reported 173,639 shares stake. Sei has 0% invested in Insulet Corporation (NASDAQ:PODD) for 12 shares. Royal Bank & Trust Of Canada has 0% invested in Insulet Corporation (NASDAQ:PODD) for 5,101 shares. Bnp Paribas Investment Sa has 0.17% invested in Insulet Corporation (NASDAQ:PODD) for 458,861 shares. Valinor Management L P reported 2.62% in Insulet Corporation (NASDAQ:PODD). Mcf Ltd Liability Corp invested in 0.02% or 2,222 shares. Loring Wolcott Coolidge Fiduciary Advsr Ltd Liability Partnership Ma reported 0% stake. Weatherbie Cap Ltd Liability Corporation owns 849,429 shares. Morgan Stanley has invested 0.01% in Insulet Corporation (NASDAQ:PODD). Northwestern Mutual Wealth Management has invested 0% in Insulet Corporation (NASDAQ:PODD). Employees Retirement Of Texas invested 0.01% in Insulet Corporation (NASDAQ:PODD). Allianz Asset Mgmt Ag holds 40,347 shares. Us State Bank De holds 2,046 shares. American Group invested in 33,175 shares.

Since March 2, 2017, it had 3 insider purchases, and 4 sales for $3.48 million activity. 40,000 shares were sold by Zakrzewski Joseph S, worth $1.87 million. Hopfield Jessica bought $99,783 worth of stock. On Monday, May 1 Lemoine David A sold $66,142 worth of Insulet Corporation (NASDAQ:PODD) or 1,524 shares. Thomas Bradley A bought 3,000 shares worth $116,077. SOMMER REGINA O had sold 40,000 shares worth $1.80M on Monday, March 13. Another trade for 2,500 shares valued at $101,470 was made by Spears Michael P on Tuesday, May 16.

Insulet (NASDAQ:PODD) Receives a Downgrade

It appears that trading for shares of Insulet (NASDAQ:PODD) will be interesting to watch today. BTIG Research decreased the stock from their past Buy rating to a more current Neutral.

Investors sentiment decreased to 0.87 in Q4 2016. Its down 0.25, from 1.12 in 2016Q3. It worsened, as 26 investors sold Insulet Corporation shares while 58 reduced holdings. 21 funds opened positions while 52 raised stakes. 60.26 million shares or 0.42% more from 60.00 million shares in 2016Q3 were reported.

Pacad Inv Ltd stated it has 0.02% of its portfolio in Insulet Corporation (NASDAQ:PODD). Blackrock Group reported 173,639 shares stake. Sei has 0% invested in Insulet Corporation (NASDAQ:PODD) for 12 shares. Royal Bank & Trust Of Canada has 0% invested in Insulet Corporation (NASDAQ:PODD) for 5,101 shares. Bnp Paribas Investment Sa has 0.17% invested in Insulet Corporation (NASDAQ:PODD) for 458,861 shares. Valinor Management L P reported 2.62% in Insulet Corporation (NASDAQ:PODD). Mcf Ltd Liability Corp invested in 0.02% or 2,222 shares. Loring Wolcott Coolidge Fiduciary Advsr Ltd Liability Partnership Ma reported 0% stake. Weatherbie Cap Ltd Liability Corporation owns 849,429 shares. Morgan Stanley has invested 0.01% in Insulet Corporation (NASDAQ:PODD). Northwestern Mutual Wealth Management has invested 0% in Insulet Corporation (NASDAQ:PODD). Employees Retirement Of Texas invested 0.01% in Insulet Corporation (NASDAQ:PODD). Allianz Asset Mgmt Ag holds 40,347 shares. Us State Bank De holds 2,046 shares. American Group invested in 33,175 shares.

Since March 2, 2017, it had 3 insider purchases, and 4 sales for $3.48 million activity. 40,000 shares were sold by Zakrzewski Joseph S, worth $1.87 million. Hopfield Jessica bought $99,783 worth of stock. On Monday, May 1 Lemoine David A sold $66,142 worth of Insulet Corporation (NASDAQ:PODD) or 1,524 shares. Thomas Bradley A bought 3,000 shares worth $116,077. SOMMER REGINA O had sold 40,000 shares worth $1.80M on Monday, March 13. Another trade for 2,500 shares valued at $101,470 was made by Spears Michael P on Tuesday, May 16.

Insulet Corporation (NASDAQ:PODD) Ratings Coverage

Among 11 analysts covering Insulet Corporation (NASDAQ:PODD), 6 have Buy rating, 1 Sell and 4 Hold. Therefore 55% are positive. Insulet Corporation has $50 highest and $15 lowest target. $40.10’s average target is -20.95% below currents $50.73 stock price. Insulet Corporation had 22 analyst reports since July 29, 2015 according to SRatingsIntel. Wedbush maintained the shares of PODD in report on Tuesday, February 28 with “Outperform” rating. The stock has “Equal-Weight” rating by Morgan Stanley on Monday, November 2. William Blair upgraded the shares of PODD in report on Friday, April 29 to “Outperform” rating. Northland Capital maintained the stock with “Outperform” rating in Friday, November 6 report. The stock of Insulet Corporation (NASDAQ:PODD) has “Hold” rating given on Monday, July 10 by Canaccord Genuity. Benchmark downgraded the shares of PODD in report on Thursday, August 13 to “Hold” rating. On Monday, July 17 the stock rating was downgraded by BTIG Research to “Hold”. The firm earned “Buy” rating on Friday, February 26 by Benchmark. The company was maintained on Thursday, August 4 by Jefferies. Robert W. Baird upgraded the shares of PODD in report on Friday, January 6 to “Outperform” rating.

It closed at $50.73 lastly. It is down 48.83% since July 17, 2016 and is uptrending. It has outperformed by 32.13% the S&P500.

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System , an insulin delivery system for people with insulin-dependent diabetes. The company has market cap of $3.00 billion. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximately three days at a time and its wireless companion, the handheld Personal Diabetes Manager (PDM). It currently has negative earnings. The Omnipod System features two discreet devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter.

More recent Insulet Corporation (NASDAQ:PODD) news were published by: Seekingalpha.com which released: “Insulet And Medtronic Join Investment In Glooko Diabetes Management” on June 28, 2017. Also Medgadget.com published the news titled: “Insulin Pump Market US Growth and 2022 Forecasts Analysis – Insulet …” on July 11, 2017. Streetinsider.com‘s news article titled: “Insulet Corporation (PODD) PT Raised to $50 at Canaccord Genuity; Reiterates Hold” with publication date: July 11, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.